CGC - Canopy Growth Corporation
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Smiths Falls,
Canada
Type: Equity
CGC price evolution
CGC
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Dec 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $142.75 | $240.38 | ||
| Short term investments | $50.71 | $37.99 | ||
| Net receivables | $63.92 | $68.9 | ||
| Inventory | $86.92 | $87.47 | ||
| Total current assets | $397.28 | $493.69 | ||
| Long term investments | $392.32 | $556.36 | ||
| Property, plant & equipment | $340.48 | $346.23 | ||
| Goodwill & intangible assets | $204.31 | $232.62 | ||
| Total noncurrent assets | $962.47 | $1174.53 | ||
| Total investments | $443.04 | $594.35 | ||
| Total assets | $1359.75 | $1668.22 | ||
| Current liabilities | ||||
| Accounts payable | $25.84 | $22.72 | ||
| Deferred revenue | ||||
| Short long term debt | $91.34 | $49.96 | ||
| Total current liabilities | $221.34 | $196.25 | ||
| Long term debt | $520.74 | $631.23 | ||
| Total noncurrent liabilities | $593.74 | $722.51 | ||
| Total debt | $612.07 | $681.19 | ||
| Total liabilities | $815.09 | $918.76 | ||
| Shareholders' equity | ||||
| Retained earnings | -$10237.69 | -$10020.9 | ||
| Other shareholder equity | -$16.05 | -$24.8 | ||
| Total shareholder equity | $544.52 | $749.33 | ||
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 30 Mar 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $677.01 | $776 | $1154.65 | $1154.65 |
| Short term investments | $117.36 | $607.87 | $1155.89 | $1162.88 |
| Net receivables | $93.99 | $96.44 | $92.44 | |
| Inventory | $148.9 | $204.39 | $367.98 | $369.48 |
| Total current assets | $1077.25 | $1737.4 | $2838.19 | $2838.19 |
| Long term investments | $568.29 | $800.33 | $708.27 | $708.27 |
| Property, plant & equipment | $499.47 | $942.78 | $1074.54 | $1074.54 |
| Goodwill & intangible assets | $274.28 | $2119.2 | $2197.52 | $2430.84 |
| Total noncurrent assets | $1361.84 | $3877.65 | $3985.29 | $3020.45 |
| Total investments | $685.65 | $1408.19 | $1864.16 | $1009.96 |
| Total assets | $2439.1 | $5615.05 | $6823.48 | $6823.48 |
| Current liabilities | ||||
| Accounts payable | $76.23 | $64.27 | $67.26 | $67.26 |
| Deferred revenue | ||||
| Short long term debt | $556.89 | $9.3 | $9.83 | $9.83 |
| Total current liabilities | $803.84 | $212.9 | $284.33 | $284.33 |
| Long term debt | $749.99 | $1491.69 | $1573.14 | $1573.14 |
| Total noncurrent liabilities | $875.23 | $1771.65 | $2917.33 | $2313.59 |
| Total debt | $1306.88 | $1500.99 | $1582.96 | $465.42 |
| Total liabilities | $1679.08 | $1984.55 | $3201.66 | $3201.66 |
| Shareholders' equity | ||||
| Retained earnings | -$9672.76 | -$6370.34 | -$6068.16 | -$6068.16 |
| Other shareholder equity | -$13.86 | -$42.28 | -$34.24 | -$34.24 |
| Total shareholder equity | $758.43 | $3589.96 | $3481.81 | $3481.81 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $78.5 | $69.59 | ||
| Cost of revenue | $50.28 | $46.17 | ||
| Gross Profit | $28.23 | $23.43 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $54.44 | $57.61 | ||
| Total operating expenses | $88.54 | $30.43 | ||
| Operating income | -$60.32 | -$7.01 | ||
| Income from continuing operations | ||||
| EBIT | -$217.87 | -$297.19 | ||
| Income tax expense | -$1.08 | $12.82 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | -$216.8 | -$310.01 | ||
| Income (for common shares) | -$216.8 | -$310.01 | ||
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 30 Mar 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $402.9 | $546.65 | $546.65 | |
| Cost of revenue | $507.04 | $479.69 | $453.7 | |
| Gross Profit | -$104.14 | $66.96 | $92.94 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $456.23 | $575.39 | $572.87 | |
| Total operating expenses | $2744.16 | $1310.42 | $1117.72 | |
| Operating income | -$2848.3 | -$1243.46 | -$571.07 | |
| Income from continuing operations | ||||
| EBIT | -$3282.93 | -$1758.06 | -$571.07 | |
| Income tax expense | -$4.77 | -$13.14 | -$13.14 | |
| Interest expense | -$8.46 | |||
| Net income | ||||
| Net income | -$3278.16 | -$1744.92 | -$1744.92 | |
| Income (for common shares) | -$3278.16 | -$1744.92 | -$1744.92 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$216.8 | -$310.01 | -$38.12 | -$711.62 |
| Operating activities | ||||
| Depreciation | $12.24 | $11.06 | $18.58 | $20.77 |
| Business acquisitions & disposals | -$3.72 | $2.5 | ||
| Stock-based compensation | $3.69 | $2.57 | $3.87 | $9.46 |
| Total cash flows from operations | -$32.57 | -$78.65 | -$148.67 | -$139.74 |
| Investing activities | ||||
| Capital expenditures | $0.77 | $68.46 | $81.32 | -$0.33 |
| Investments | -$12.72 | $8.79 | $71.75 | $87.3 |
| Total cash flows from investing | -$0.61 | $60.14 | $142.57 | $91.25 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $33.8 | $0.2 | ||
| Net borrowings | -$64.89 | -$296.91 | -$118.28 | $134.93 |
| Total cash flows from financing | -$66.23 | -$274.19 | -$133.11 | $126.23 |
| Effect of exchange rate | -$0.82 | $2.4 | -$4.53 | $1.13 |
| Change in cash and equivalents | -$100.23 | -$290.29 | -$143.74 | $78.88 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Mar 2021 |
|---|---|---|---|---|
| Net income | -$3278.16 | -$302.18 | -$1744.92 | -$1744.92 |
| Operating activities | ||||
| Depreciation | $84.52 | $114.42 | $127.12 | $127.12 |
| Business acquisitions & disposals | -$9.29 | $103.2 | -$219.92 | |
| Stock-based compensation | $31.19 | $47.52 | $91.15 | |
| Total cash flows from operations | -$557.55 | -$545.81 | -$465.73 | -$465.73 |
| Investing activities | ||||
| Capital expenditures | $4.39 | -$9.4 | -$158.43 | -$164.5 |
| Investments | $435.44 | $166.58 | -$514.45 | -$497.56 |
| Total cash flows from investing | $433.38 | $230.82 | -$884.11 | -$884.11 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.33 | $8.27 | $402.08 | |
| Net borrowings | $16.98 | -$50.76 | $861.44 | $877.54 |
| Total cash flows from financing | -$19.69 | -$45.53 | $1264.77 | $1264.77 |
| Effect of exchange rate | $44.86 | -$18.12 | -$63.46 | -$63.46 |
| Change in cash and equivalents | -$99 | -$378.65 | -$148.52 | -$148.52 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 2.21 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |